NCT03741231
- Conditions
- 18F-FDG, Immunotherapy, Melanoma, +13 more
- Locations
-
- CHRU de Brest Brest, France
- CH de LANDERNEAU Landerneau, France
- Centre Hospitalier de Morlaix Morlaix, France
Clinical trial condition
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
NCT03741231
NCT02251314
NCT03155217
NCT02117362
NCT02122861
NCT01290536
Not specified
NCT00223899
NCT00470015
NCT02668887
NCT00844064